National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 10) (No. PB 71 of 2013) (Cth)

PB 71 of 2013

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 10)

National Health Act 1953

___________________________________________________________________________

I, Steve Dunlop, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated   16    October 2013

STEVE DUNLOP

Acting Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.10).

(2)This Instrument may also be cited as PB 71 of 2013.

2             Commencement

This Instrument commences on 1 November 2013.

3              Amendments to PB 79 of 2011

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1                   Amendments

1. Schedule 1 Part 1, under the entry for the listed drug Docetaxel, in the form ‘Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent’ with manner of administration ‘Injection’

omit:

Taxotere SW MP C3888 C3892 C3916
C3956
C4078
C4140
C4160
C4239 D